Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

The Journal of clinical psychiatry

Volumn 66, Issue 1, 2005, Pages 41-48

  Raison, Charles L ^a   Borisov, Andrey S ^a   Broadwell, Sherry D ^a   Capuron, Lucile ^a   Woolwine, Bobbi J ^a   Jacobson, Ira M ^a   Nemeroff, Charles B ^a   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; DRUG CARRIER; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BUCCAL DRUG ADMINISTRATION; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PERSONALITY TEST; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; VIROLOGY;

ADMINISTRATION, BUCCAL; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RIBAVIRIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 13844306621     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0106     Document Type: Article

References (0)